Literature DB >> 28799019

Endometriosis and the risk of skin cancer: a prospective cohort study.

Leslie V Farland1,2, Simon Lorrain3, Stacey A Missmer1,4,5, Laureen Dartois6,7, Iris Cervenka6,7, Isabelle Savoye6,7, Sylvie Mesrine6,7, Marie-Christine Boutron-Ruault6,7, Marina Kvaskoff8,9.   

Abstract

PURPOSE: Endometriosis has been associated with an increased risk of skin melanoma. However, associations with other skin cancer types and how they compare with melanoma are unclear. Our objective was to prospectively investigate the relationships between endometriosis and risk of non-melanoma and melanoma skin cancers.
METHODS: E3N is a prospective cohort of 98,995 French women aged 40-65 years in 1990. Data on surgically confirmed endometriosis and skin cancer diagnoses were collected every 2-3 years through self-report, with skin cancer cases confirmed through pathology reports. Hazard Ratios (HR) and 95% confidence intervals (CIs) were calculated using Cox regression models.
RESULTS: Between 1990 and 2008, 535 melanoma, 247 squamous-cell carcinoma (SCC), and 1,712 basal-cell carcinoma (BCC) cases were ascertained. Endometriosis was associated with an increased overall risk of skin cancer (HR 1.28, 95% CI 1.05-1.55). When considering skin cancer type, endometriosis was associated with melanoma risk (HR 1.64, 95% CI 1.15-2.35), but not with SCC (HR 1.21, 95% CI 0.62-2.36) or BCC (HR 1.16, 95% CI 0.91-1.48) (non-melanoma skin cancers combined: HR 1.17, 95% CI 0.93-1.46), although no heterogeneity was detected across skin cancer types (Phomogeneity = 0.13).
CONCLUSION: These data support an association between a personal history of endometriosis and the risk of skin cancer and suggest that the association is strongest for melanoma.

Entities:  

Keywords:  Cohort studies; Cutaneous melanoma; Endometriosis; Epidemiology; Skin cancer

Mesh:

Year:  2017        PMID: 28799019      PMCID: PMC5693730          DOI: 10.1007/s10552-017-0939-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  55 in total

Review 1.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

2.  Organochlorine pesticides and endometriosis.

Authors:  Maureen A Cooney; Germaine M Buck Louis; Mary L Hediger; Albert Vexler; Paul J Kostyniak
Journal:  Reprod Toxicol       Date:  2010-05-16       Impact factor: 3.143

3.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

4.  Mediation analysis.

Authors:  David P MacKinnon; Amanda J Fairchild; Matthew S Fritz
Journal:  Annu Rev Psychol       Date:  2007       Impact factor: 24.137

5.  Endometriosis and the risk of cancer with special emphasis on ovarian cancer.

Authors:  A Melin; P Sparén; I Persson; A Bergqvist
Journal:  Hum Reprod       Date:  2006-01-23       Impact factor: 6.918

6.  Incidence of endometriosis by study population and diagnostic method: the ENDO study.

Authors:  Germaine M Buck Louis; Mary L Hediger; C Matthew Peterson; Mary Croughan; Rajeshwari Sundaram; Joseph Stanford; Zhen Chen; Victor Y Fujimoto; Michael W Varner; Ann Trumble; Linda C Giudice
Journal:  Fertil Steril       Date:  2011-06-29       Impact factor: 7.329

7.  IRF4 variants have age-specific effects on nevus count and predispose to melanoma.

Authors:  David L Duffy; Mark M Iles; Dan Glass; Gu Zhu; Jennifer H Barrett; Veronica Höiom; Zhen Z Zhao; Richard A Sturm; Nicole Soranzo; Chris Hammond; Marina Kvaskoff; David C Whiteman; Massimo Mangino; Johan Hansson; Julia A Newton-Bishop; Veronique Bataille; Nicholas K Hayward; Nicholas G Martin; D Timothy Bishop; Timothy D Spector; Grant W Montgomery
Journal:  Am J Hum Genet       Date:  2010-06-17       Impact factor: 11.025

8.  Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection.

Authors:  David C Whiteman; Robyn M Brown; David M Purdie; Maria-Celia Hughes
Journal:  J Am Acad Dermatol       Date:  2005-01       Impact factor: 11.527

9.  Cancers, infections, and endocrine diseases in women with endometriosis.

Authors:  Julie Anne L Gemmill; Pamela Stratton; Sean D Cleary; Mary Lou Ballweg; Ninet Sinaii
Journal:  Fertil Steril       Date:  2009-11-27       Impact factor: 7.329

10.  The risk of cancer and the role of parity among women with endometriosis.

Authors:  A Melin; P Sparén; A Bergqvist
Journal:  Hum Reprod       Date:  2007-09-13       Impact factor: 6.918

View more
  5 in total

1.  Recreational and residential sun exposure and risk of endometriosis: a prospective cohort study.

Authors:  Leslie V Farland; William J Degnan; Holly R Harris; Jiali Han; Eunyoung Cho; Trang VoPham; Marina Kvaskoff; Stacey A Missmer
Journal:  Hum Reprod       Date:  2021-01-01       Impact factor: 6.918

2.  Endometriosis, Psoriasis, and Psoriatic Arthritis: A Prospective Cohort Study.

Authors:  Holly R Harris; Karen Moreno Nascimento Korkes; Tricia Li; Marina Kvaskoff; Eunyoung Cho; Luiz Fernando Carvalho; Abrar A Qureshi; Mauricio Abrao; Stacey A Missmer
Journal:  Am J Epidemiol       Date:  2022-05-20       Impact factor: 5.363

3.  Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis.

Authors:  Yeon Jean Cho; Jiyeun E Lee; Mi Jin Park; Bert W O'Malley; Sang Jun Han
Journal:  J Endocrinol       Date:  2018-04-10       Impact factor: 4.286

4.  Long-term Health Consequences of Endometriosis - Pathways and Mediation by Treatment.

Authors:  Leslie V Farland; Holly R Harris
Journal:  Curr Obstet Gynecol Rep       Date:  2020-05-29

5.  HOX cluster and their cofactors showed an altered expression pattern in eutopic and ectopic endometriosis tissues.

Authors:  Fereshteh Esfandiari; Fereshteh Chitsazian; Masoumeh Golestan Jahromi; Raha Favaedi; Masood Bazrgar; Reza Aflatoonian; Parvaneh Afsharian; Abbas Aflatoonian; Maryam Shahhoseini
Journal:  Reprod Biol Endocrinol       Date:  2021-09-01       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.